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In Brief
Surveying gene expression and SNP genotypes across immune cell types from healthy humans reveals cis-eQTLs affecting over half of all expressed genes and demonstrates that variant effects often manifest in cell types other than those with highest gene expression.
INTRODUCTION
Genomic surveys of individuals from multiple populations have revealed significant genetic heterogeneity, with over 80 million autosomal single nucleotide polymorphisms (SNPs), including $8 million common variants (Auton et al., 2015) . Disease risk associations for several thousand of these SNPs have been identified by genome-wide association studies (GWAS) (Visscher et al., 2012) ; however, the overwhelming majority of GWAS hits lie in non-coding regions of the genome, and thus, very little is known about exactly which genes they effect, in which cell types they act, and what their functional relevance is to disease. In parallel, large-scale epigenomic initiatives analyzing multiple human cell types have attributed cis-regulatory function to nearly 20% of the non-coding DNA sequences and showed that disease risk variants are enriched in cell-specific cisregulatory DNA sequences (Kundaje et al., 2015) . This indicates that disease risk variants are likely to affect gene expression in a context-dependent manner, in a specific subset of cell types in the human body. Defining the cell types in which disease risk variants modulate gene expression will aid mechanistic and functional studies that investigate the genetic basis of specific diseases.
The Genotype-Tissue Expression (GTEx) consortium assessed the association of genetic variants with gene expression levels (expression quantitative trait loci or eQTLs) across 44 human tissues (GTEx Consortium, 2015; Battle et al., 2017) . Its results provide a valuable resource for narrowing down tissue-specific cis-regulatory effects of disease risk variants, but the results do not provide information on eQTLs in immune cell types. Previous large-scale eQTL studies of cells in the human immune system were performed in heterogeneous cell types and cell lines (Grundberg et al., 2012; Wright et al., 2014; Zhernakova et al., 2017) or in a relatively small number of homogeneous cell types from the same study subjects, thus limiting cell-specific eQTL analyses (Chen et al., 2016; Fairfax et al., 2014; Lee et al., 2014; Quach et al., 2016; Raj et al., 2014) . The DICE (database of immune cell expression, expression quantitative trait loci (eQTLs) and epigenomics) project was established to define the transcriptional and epigenomic landscape of many human immune cell types in relation to genetic variation, thereby identifying both the cell-type restriction and potential function of human disease-associated SNPs.
In this first report from the DICE project, we identified common genetic variants that are associated with the expression of several thousand protein-coding and non-coding RNAs in 13 types of immune cells and 2 activation conditions, providing a map as to how human genetic variations affect gene expression in immune cell types. We have built a central resource (https://dice-database. org) to integrate and disseminate our datasets and to allow scientists to predict the effects of disease-associated genetic variants in immune cell types, thus connecting the genetic risk of disease to cell types and molecular pathways.
RESULTS
Transcriptome of Common Human Immune Cell Types
In the first phase of the DICE project, we present transcriptomic data generated from 13 immune cell types isolated from 106 leukapheresis samples provided by 91 healthy subjects, including 15 who provided longitudinal samples. The cell types presented here comprise over 60% of all circulating mononuclear cells and include three innate immune cell types (CD14 high CD16classical monocytes, CD14 -CD16 + non-classical monocytes, CD56 dim CD16 + NK cells), four adaptive immune cell types that have not encountered cognate antigen in the periphery (naive B cells, naive CD4 + T cells, naive CD8 + T cells, and naive regulatory T cells [T REG ]), six CD4 + memory or more differentiated T cell subsets (T H 1, T H 1/17, T H 17, T H 2, follicular helper T cell [T FH ], and memory T REG ), and two activated cell types (naive CD4 + and CD8 + T cells that were stimulated ex vivo) (Figures 1A, 1B , and S1A-S1F and Table S1 ).
RNA-seq analysis showed that similar numbers of transcripts (ranging from 14,500-17,000, $39% of all annotated transcripts) were detected (> 1.0 transcripts per million, TPM) across all cell types and activation conditions ( Figure 1C ). About 18% of these transcripts were long-noncoding RNAs (lncRNAs) ( Figure 1D ), which as a class were expressed at lower levels compared to protein-coding transcripts ( Figure S1G ). Though a majority of transcripts were detected in multiple cell types (Figures S1H and S1I), their relative abundance varied substantially, resulting in distinct clustering patterns of different cell types ( Figure 1E ).
Cell-Specific Transcriptional Signatures
We classified the differentially expressed transcripts into groups that had significantly higher expression in one cell type than in Figure S1 and Table S1A ). (C) RNA-seq analysis of 1,544 samples (details provided in Table S1B ) showing the total number of detected transcripts categorized based on their mean expression levels (TPM, transcript per million) in the indicated cell types and activation conditions. (D) The fraction of expressed transcripts belonging to each biotype as defined in the Ensembl database. For comparison, the GRCh37.p13 bar shows the corresponding fractions for all 57,820 annotated transcripts in the reference genome. (E) Unsupervised hierarchical clustering of the transcriptomes of the indicated cell types based on the 1,000 most variable transcripts expressed; each line represents an independent sample. the others (Figure 2 and Table S2 ). 4,602 transcripts showed highly cell-specific expression patterns (Figure 2A ) and were classified as cell-specific protein-coding transcripts, including several whose function is well-known (CD163, SIGLEC10, GZMB, FCRL2, CD40LG, and CRTAM) and others where it is still poorly defined in the respective cell type (PADI4, CLEC4F, C1orf21, TSPAN13, and FHIT) (Figures 2A and 2B) . Interestingly, several lncRNAs showed high abundance in specific immune cell types. Though very little is known about their function, the cell specificity of their expression raises the speculation that these lncRNAs may have an important role in the development and/or function of the respective immune cell type.
Differential gene expression analysis among the CD4 + T cell subsets revealed over 700 genes that were enriched for expression in one specific CD4 + T cell subset ( Figure 2C ). Besides known CD4 + T cell subset-specific genes (e.g., FOXP3 in T REG cells, IL17A in T H 17 cells, CXCR5 in T FH cells), several novel protein-coding transcripts and lncRNAs (e.g., RP11-265P11.2 A B C D Figure 2 . Cell-Specific Transcriptional Signatures (A and C) RNA-seq analysis showing differentially expressed genes (STAR Methods), presented as row-wise Z scores of normalized TPM counts in the indicated cell types. (B and D) t-SNE plots of transcriptomes (symbol) for each of the indicated cell types for all subjects, and the expression of indicated cell-specific transcripts in each subject is shown in corresponding plots. Each symbol represents an independent sample; color scale represents the Z scores of normalized TPM counts in the indicated cell types.
in naive T REG cells, AP001189.4 in memory T REG cells, GPR56 in T H 1 cells, TNFRSF11A in T H 2 cells), whose function has not been fully characterized, with cell-specific expression patterns in CD4 + T cell subsets were identified ( Figures 2C and 2D ). Overall, these findings emphasize the value of this resource in defining a reference for cell-specific transcripts, several of which may have important functional roles in the respective cell types.
Expression QTLs Are Highly Cell Specific
We identified common single-nucleotide polymorphisms (SNPs) associated with variation in transcript abundance of a nearby gene, which we refer to as cis-eQTLs for convenience. Considering all immune cell types and including differences related to activation of naive CD4 + and CD8 + T cells, we identified cis-eQTLs for a total of 12,254 unique genes, representing 61% of all expressed protein-coding genes and 49% of all lncRNAs, respectively, and a majority of these were replicated in other eQTL studies ( Figure 3A and Table S3 ). For simplicity, genes with at least one significant cis-eQTL in any cell type are hereafter referred to as eGenes. The cis-eQTLs were enriched within intronic regions of the genome ( Figure 3B ) and 12% of all cis-eQTLs were located within ± 10 kb of the TSS ( Figure 3C ). However, 37% of all cis-eQTLs were located >100 kb from the TSS of the target gene ( Figure 3C ), suggesting that genetic variants may correlate with expression of more distant target genes. We identified >2,000 eGenes (ranging from 2,421-3,590 eGenes per cell type) for each of the indicated six common cell types ( Figure 3D ), and the majority (51%) of these genes showed a significant cis-association with genotype only in one specific cell type ( Figures 3E-3G ). The cell specificity of SNPs' association was not entirely due to cell-specific expression of eGenes, as these associations were observed even for genes that were expressed at similar levels across multiple cell types, with some cell types highly susceptible to the effect of the SNP and others not susceptible (Figures 3F, 3G, and S2A) . For example, IRAK3 showed a peak cis-eQTL (rs1732886, adj. association p = 6.82 3 10 À17 ) only in naive B cells even though it was expressed at even higher levels in classical and non-classical monocytes ( Figure 3G ). IRAK3 is a member of the interleukin-1 receptor-associated kinase family and known to function as a negative regulator of Toll-like receptor (TLR) signaling regulating immune homeostasis and tolerance (Hubbard and Moore, 2010) .
Additional examples of cell-specific eGenes that we identified include two genes in the CD96 locus that showed strong cis-eQTLs exclusively in naive B cells (rs149612031, adj. association p = 3.01 3 10 À16 for CD96 and 1.81 3 10 À16 for ZBED2, respectively; Figures 3G and S2A ). Homozygosity of the GA allele of rs149612031 (64% of our subjects) was associated with lack of expression of the CD96 and ZBED2 transcripts in B cells, but not in other cell types such as NK cells and T cells, suggesting that these genetic variants, if causally linked to gene expression, profoundly affect only susceptible cell types. CD96 belongs to the immunoglobulin family of receptors that bind to nectin-like proteins and is expressed by NK cells and T cells where it functions as an important negative regulator of cellular activation and cytokine responses (Chan et al., 2014) ; ZBED2 is a transcription factor. An interesting eQTL (rs2511162) associated with GAB2 showed inverse effects on gene expression in B cells versus T cells; rs2511162 A/A was associated with lower GAB2 expression in B cells, whereas in T cells, it was associated with increased expression of GAB2. Knocking down GAB2 expression in naive CD4 + T cells resulted in a significant reduction in the expression of activation markers (CD69, CD25, and HLA-DR) and cytokine transcripts (IFNG and IL2) following anti-CD3 and anti-CD28 stimulation ( Figures  S2B-S2D ). GAB2 has previously been shown to be an important adaptor protein involved in B and T cell signaling pathways (Osinalde et al., 2016) ; thus, if this genetic variant modulates GAB2 protein expression, there could be divergent functional consequences in T cells and in B cells.
A $240 kb dense haploblock of NK cell-and CD8 + T cell-specific cis-eQTLs at the 12p13.2 locus was associated with the expression of three lncRNAs and six C-type lectin-like receptors, including 5 activating NK receptors (KLRK1, KLRC4-KLRK1, KLRC4, KLRC3, and KLRC2) and an inhibitory receptor (KLRC1) ( Figure 3H , top panel). Non-coding SNPs in general have previously been shown to perturb the function of cellspecific enhancers and thus affect gene expression in specific cell types (Schmiedel et al., 2016) . As expected, several of the cis-eQTLs in the 12p13.2 locus directly overlapped many cellspecific DNase sites present in NK cells and naive CD8 + T cells ( Figure 3H , middle panel). The G allele at rs2927561 was associated with increased expression of all five activating NK receptors and two lncRNAs in the locus, which suggested that this allele, if causally linked to gene expression, is likely to confer NK cells with an enhanced activation potential (Figures 3G and 3H, bottom panel) . Given the importance of NK cells in anti-viral and tumor immunity, it would be interesting to test whether the 12p13.2 genetic variants that correlate with expression of an important group of NK receptors could have donorspecific consequences.
Previous studies have reported that several genetic variants are associated with gene expression only following perturbation of resting immune cells by relevant environmental (extrinsic) stimuli (Fairfax et al., 2014; Lee et al., 2014) . To uncover such environment-responsive cis-eQTLs, we activated naive CD4 + and CD8 + T cells ex vivo and analyzed the association of SNPs with gene expression in an activation-induced manner. We identified additional cis-eQTLs for >1,300 genes exclusively in activated naive CD4 + and/or CD8 + T cells ( Figure 3I and Table  S3A ). These activation-induced eQTLs were associated with several genes encoding products known to influence T cell function, such as, the immune checkpoint molecule PDCD1 (PD-1) (Keir et al., 2008) , the co-stimulatory molecule TNFRSF9 (4-1BB) (Watts, 2005) , the co-inhibitory molecule CD59 (Sivasankar et al., 2009) and SGK1 (Wu et al., 2013) , a kinase that regulates differentiation of T H 17 and T H 2 cells (Figure 3J and Figure S2E) . In a time course experiment, we confirmed that following activation, a greater proportion of CD4 + T cells expressed cell surface 4-1BB protein in subjects with the TNFRSF9 (4-1BB) expression-increasing allele (T/T genotype at rs9657975) compared to those with C/C genotype ( Figure 3K ). This effect was not observed for other markers of activation such as CD69, CD25 or HLA-DR ( Figure 3K and Figure S2F ), which suggested that despite similar levels of activation, 4-1BB protein expression differed based on genotype. Since 4-1BB is currently tested as a co-stimulatory cancer immunotherapy target (Chester et al., 2018) , our description of genotype-dependent effects on expression of 4-1BB in T cells may aid in the development of genetic biomarkers that stratify potential responders to 4-1BB targeted therapies.
CD4 + T Cell Subset-Specific eQTLs Naive CD4 + T cells when activated in vivo following pathogen exposure, differentiate into several lineage-specific memory subsets such as T H 1, T H 1/17, T H 17, T H 2, and T FH subsets (Zhou et al., 2009) , which have distinct gene expression programs and functional roles in host defense ( Figure 2C ). Naive T REG cells are another important CD4 + T cell lineage that develops in the thymus and differentiates into memory T REG cells in the periphery where they play an immune regulatory role (Sakaguchi et al., 2010) . Our eQTL analysis of CD4 + memory and T REG subsets yielded over 7,800 eGenes, of which >2,500 were unique to these subsets ( Figure 4A ). Further, we identified >2,000 eGenes (ranging from 2,381-3,560 eGenes per cell type, Figure 4B ) for each of the eight CD4 + T cell subsets, and a large proportion (44%) of these genes showed a significant cis-association with genotype only in one cell type (Figures 4C and 4D) .
A noteworthy example of an eGene specific to the CD4 + memory and T REG subsets was ENTPD1 that encodes for CD39, a cell-surface ectonucleotidase, which has been widely considered to play a role in the generation of immunosuppressive microenvironments through adenosine production from ATP (Takenaka et al., 2016) . Several other eGenes showed highly cell-type-restricted effects ( Figure 4E ); for example, CCNG2, encoding for a cell cycle protein, cyclin G2, showed a peak eQTL (rs4859751) specifically in T H 1/17 and T H 17 cells although it was also highly expressed in other T H subsets and immune cell types; whereas NCF4, which encodes neutrophilic cytosolic factor 4, a component of the NADPH oxidase complex, showed prominent cis-QTLs specifically in CD4 + T subsets ( Figure 4E ).
We also identified two genes in the Fc receptor like (FCRL) gene locus that showed strong cis-eQTLs primarily in T REG subsets (rs2065883, adj. association p = 5.6 3 10 À18 for FCRL1 and 3.8 3 10 À18 for FCRL2 and 1.81 3 10 À16 in naive T REG cells, respectively; Figure 4E ). The function of FCRL1 and FCRL2 in T REG cells is not known, but given its role in modulating B cell receptor signaling pathway in B cell subsets Rostamzadeh et al., 2018) , where it is highly expressed, it is conceivable that these proteins may module T REG activation and function in a genotype dependent manner. Our data emphasize the importance of studying purified, homogeneous cell types to identify cells and genes most susceptible to the effects of genetic variants. It will also be important to confirm directly that the SNPs indeed affect the biological functions of the corresponding cell types, using appropriate experimental systems of development or activation.
Cell Types Most Susceptible to GWAS SNPs
To shed light on the disease relevance of the eQTLs identified in human immune cells, we next focused on the subset of eGenes linked to eQTLs that directly overlapped haploblocks of significant GWAS SNPs (P GWAS < 5 3 10 À8 ) that were associated with one or more of 846 unique human diseases and traits (Table S4 and STAR Methods). Most importantly, about 19% of all the eGenes identified in each human immune cell type (2,297 unique GWAS eGenes; 599-987 eGenes per cell type) were also associated with GWAS SNPs ( Figures  5A and 5B) , and for about 36% of the eGenes, associations were observed in only one or two cell types ( Figure S3A ). Together, these results suggest that disease risk alleles may have a profound impact on immune cell gene expression and that their effects may be highly restricted to specific cell types.
In Figures 5C and S4 and Table S4 , we highlight the cell types that are most susceptible to the potential effects of genetic (J) Mean expression levels (TPM) of eGenes in resting and activated naive CD4 + and CD8 + T cells from subjects categorized based on the genotype; each symbol represents an individual subject; * adj. association p < 0.05. (K) FACS analysis of surface expression of 4-1BB and CD25 in naive CD4 + T cells following stimulation at the indicated time points. The subjects (n = 13) were categorized based on the genotype of the cis-eQTL associated with TNFRSF9 (4-1BB) expression (C/C or T/T genotype at rs9657975); results of two-way ANOVA testing for significant differences between both groups are indicated for each surface marker. variants associated with common immune-mediated diseases. rs12936231, a variant associated with several autoimmune diseases and asthma, whose functional effects have been previously described (Schmiedel et al., 2016) , is associated with the modulation of expression of ORMDL3 and GSDMB in lymphocyte subsets and not in cells of myeloid origin. In contrast, the ERAP2 peak eQTL (rs2548540), which was also a lead GWAS SNP for multiple autoimmune diseases, caused genotype-dependent expression differences across all the immune cell types studied ( Figure S3B ).
Coding and non-coding polymorphisms in the LACC1 gene, encoding for the protein FAMIN (fatty acid metabolism-immunity nexus) that drives fatty acid oxidation and ATP regeneration, were previously shown to be associated with increased risk of Crohn's disease (CD). Due to its strong expression in macrophages, studies on the function of FAMIN and its loss-of-function variants have so far focused on this cell type where it was shown to control inflammasome activation (Cader et al., 2016) and the release of pro-inflammatory cytokines in response to TLR signaling (Lahiri et al., 2017) . However, we observed that LACC1 was upregulated more than 10-fold following activation of T cells, and most importantly, the CD-risk variant (rs9567293 C/C ) was associated with reduced expression of LACC1 in CD4 + memory T cell subsets, as well as in resting and activated naive T cells but not in monocytes (Figures 5D and S3C) . We therefore tested whether the function of T cells was affected by FAMIN. As FAMIN modulated TLR signaling responses in monocytes, we specifically tested the role of FAMIN in T cell responses to TLR co-stimulation. We found that LACC1 knockdown in CD4 + T cells when compared to control siRNA treatment resulted in significantly reduced activation (CD25 and HLA-DR surface expression) and expression of cytokine transcripts (IFNG and IL2) following TLR1/2 co-stimulation and CD3/CD28 stimulation . This result suggested that the reduced LACC1 levels observed in subjects carrying the CD-risk variant (rs9567293 C/C ) is likely to have important functional consequences in their T cells and, thus, raised the hypothesis that T cells may be dominant players in driving the LACC1-related genetic risk of Crohn's disease.
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We identified several eQTLs that influenced the expression of genes associated by GWAS studies with risk for the rare autoimmune disease primary biliary cholangitis (PBC), including NAB1 and SYNGR1. Interestingly, we found that the expression of NAB1 displayed prominent genotype-dependent association (rs13028201, adj. association p = 1.41 3 10 À14 ) only in NK cells ( Figures 5F and S3C ), though it was widely expressed across all the other immune cell types studied. NAB1 is a corepressor for early growth response (EGR) transcription factors and its mouse homolog NAB2 has been shown to be required for preventing activation-induced cell death in CD8 + T cells that received CD4 + T cell help (Wolkers et al., 2012) . The PBC-risk variant rs74804869 influenced SYNGR1 expression in NK and also CD8 + T cells ( Figures 5F and S3C ). To date, no studies have examined the functional role of NAB1 or SYNGR1 in NK cells or linked NK cells to PBC pathogenesis. Thus, our results are likely to generate hypothesis that motivate further investigation. As a first step in that process, we knocked down these genes in human NK cells and tested their impact on NK cell activity (Fauriat et al., 2010) . We found that reducing NAB1 expression in NK cells significantly reduced the release of pro-inflammatory cytokines/chemokines such as IFN-g, MIP-1b, RANTES and TNF by human NK cells activated by IgG crosslinking (Figures 5G,  S3G , and S3H). NAB1 knockdown also reduced IFN-g release when NK cells were activated by co-culture with MHC devoid K-562 cancer cells ( Figure 5H ). Knocking down SYNGR1 also impacted cytokine production by activated NK cells ( Figures  5G, 5H , S3G, and S3H). Together, these results suggested that PBC-risk variants that modulate NAB1 and SYNGR1 expression are likely to impact NK cell function and influence PBC disease susceptibility.
The expression of several lncRNAs was influenced by diseaserisk SNPs in a cell-restricted manner. For example, NK cells displayed highly significant eQTLs associated with the lncRNAs RP11-973H7.1 and RP11-305L7.1. T cell subsets showed an association between RP11-77C3.3 and a SNP linked to type 1 diabetes ( Figures 5C, S4 , and S5A). These associations suggest that these lncRNAs may play an important role in disease pathogenesis, although this requires further study.
Interesting examples of disease-risk variants that display celltype-restricted effects in specific CD4 + T memory subsets (Figures 5C , S4, and S5B) include an RA-risk variant (rs3093026) and celiac disease-risk variant (rs7374671) that were associated with expression of chemokine receptor genes CCR6 and CCR2, respectively, in T H 1/17 and T H 17 subsets. A CD-risk variant (rs528101238) was associated with expression of EDN3, encoding for endothelin 3, mainly in T H 2 cells ( Figures 5C and S5B ), and notably, endothelin signaling has been shown modulate T cell function (Tanaka et al., 2014) . T FH cells that play an important role in ''helping'' B cell responses showed a prominent association for an eGene (TSPAN32) linked to a B cell malignancy (chronic lymphocytic leukemia, CLL). Interestingly, Tspan32deficent murine T cells have been shown to exhibit increased proliferative responses (Tarrant et al., 2002) , thus raising speculation about the role of this protein in modulating T FH cell-B cell help function to drive the genetic risk linked to CLL.
T REG cells were most susceptible to the effects of several autoimmune disease-risk variants. Notable eGenes associated with these variants include IKZF4, PDE4A, and PTGIR (Figures 5C, Figure 5 . Cell Types Susceptible to GWAS SNPs (A) Fraction of eGenes overlapping with significant SNPs (P GWAS < 5 3 10 À8 ) that emerged from the catalog of GWAS studies (GWAS SNPs) comprising 540 unique human diseases and traits (Table S4 and STAR Methods). (B) The total number of eGenes identified across the indicated cell types and activation conditions. (C) For each disease, the adj. association p value for the peak cis-eQTL with the indicated GWAS eGenes, excluding HLA genes, in each cell type and activation condition is shown. Example eGenes discussed in the results are printed in bold. (D) Mean expression levels (TPM) of LACC1 in the indicated cell types and activation conditions from subjects categorized based on the genotype at the cis-eQTL rs9567293; each dot represents an individual subject; * adj. association p < 0.05. (E) Real-time PCR quantification of the effects of LACC1 knockdown on the induction of IFNG and IL2 expression in naive CD4 + T cells activated for 6 hr with antibodies to CD3 and CD28 in absence or presence of the TLR1/2 ligand Pam3CSK4 (n = 5); *p < 0.05 by Student's paired two-tailed t test; NS, not significant. (legend continued on next page) 5I, and S5B). EOS, encoded by IKZF4, is a transcription factor that is required for the suppression of several FOXP3 target genes (Pan et al., 2009 ). More recently, it has been shown that downregulation of EOS leads to T REG plasticity, which can result in pathogenic conversion of T REG to effector cells in autoimmune diseases (Sharma et al., 2013) . Therefore, we speculate that T REG cells from carriers with the IKZF4 expression-reducing autoimmune disease risk-allele (rs1701704 C/C [Hakonarson et al., 2008] in tight linkage with rs2640562 T/T ) may be more susceptible to conversion to pathogenic effector cells in autoimmune diseases. Phosphodiesterase 4A, encoded by PDE4A, hydrolyzes the second messenger cAMP that is known to play an important role in driving immunosuppressive signals in T cells, and T REG cells may also transfer cAMP through gap junctions into effector cells to dampen their functional responsiveness (Wehbi and Taské n, 2016) . Whereas, prostaglandin I2 (PGI2) signaling through the PGI2 receptor (IP), encoded by PTGIR, increases intracellular cAMP levels, and recent studies in Ptgir-deficient T cells have shown an important role of PGI2-IP signaling in T REG development and function (Bloodworth et al., 2016; Liu et al., 2013) . Thus, the products of autoimmune risk-eGenes PDE4A and PTGIR are likely to modulate cAMPmediated immunoregulation and influence disease pathogenesis. Our results suggested that genotype-dependent perturbations in the expression patterns of several important genes involved in human T REG function are likely to have an impact on autoimmune disease pathogenesis.
Overall, these examples show that the effects of disease risk alleles may not necessarily be most prominent in the cell type in which the associated gene is most highly expressed. Studies of the functional impact of these alleles should therefore focus on the cell types most susceptible to their expression-modulating effects.
Sex Has Major Effects on Immune Cell Gene Expression
It is well known that immune responses in humans and model organisms are different between sexes. For example, females mount more robust innate and antibody responses to infections and vaccination, but also display increased susceptibility to many autoimmune diseases (Klein and Flanagan, 2016) . To determine if sex as a biological factor significantly influences the transcriptome of immune cells, we performed differential gene expression (DE) analysis between sexes considering ancestry and age as covariates. 1,875 unique transcripts, including 1,553 protein-coding transcripts and 196 lncRNAs, were differentially expressed between sexes (''sex-biased transcripts'') across all the cell types investigated in this study, of which 93% were transcribed from autosomes ( Figures 6A and 6B and Table S5A ). The majority (> 72%) of these transcripts showed pronounced sex-biased expression pattern in only a single immune cell type, suggesting that sex-related transcriptional differences are highly cell-specific ( Figures 6C and S6A) .
Independent pathway analysis of female-biased transcripts for each cell type revealed enrichment of genes encoding products involved in the canonical interferon and pattern recognition receptor pathways (Table S5B ). For example, in classical monocytes alone, over 50 transcripts linked to the interferon pathway, including inflammatory cytokines and chemokines like IL6, TNF, and CXCL10 displayed sex-biased expression, and enhanced expression was very prominent in some female subjects (Figures 6D and 6E) . Interferons (type 1 and type 2), interferon regulatory factors (IRFs), toll-like receptors (TLRs), and TLR ligands were also predicted by ingenuity pathway analysis (IPA) to be upstream regulators of sex-biased transcripts ( Figure 6E and Table S5C ).
Several female-biased transcripts we identified are worthy of specific mention. FAM13A (family with sequence similarity 13 gene) was expressed at higher levels in the naive CD4 + T cells of female subjects. We also found a cis-eQTL (rs1246642) whose impact on expression was stronger in female subjects ( Figures  6F, 6G , S6B, and S6C); homozygous females carrying the CC versus TT genotype had 3.5-fold greater levels of FAM13A transcripts compared to a < 1.5-fold increase in males. This effect was also observed in T H 1/17, T H 17 and T FH CD4 + T cell subsets ( Figures S6B and S6C ). GWAS studies have strongly implicated FAM13A as a susceptibility gene for chronic obstructive pulmonary disease (COPD) (Cho et al., 2014) , and subjects with the risk alleles express higher levels of FAM13A in lung tissue (Kim et al., 2014) . The higher expression of FAM13A among females that we found may help to explain their greater risk for developing severe early onset COPD with less cigarette-smoking exposure compared to males (Aryal et al., 2014) . Further, our studies point to CD4 + T cells, especially from females, as highly susceptible to the effects of COPD-risk alleles in the FAM13A locus. To (D) Ingenuity pathway analysis of sex-biased transcripts identified in classical monocytes that are regulated by interferon-g and encode products with various functions (key indicates product type). (E) Column-wise Z scores of TPM counts for transcripts in the interferon (IFN, left panel), interferon regulatory factor (IRF, middle panel) and toll-like receptor (TLR, right panel) response pathways expressed in classical monocytes; each row represents an individual subject. (F) Mean expression levels (TPM) of sex-biased transcript FAM13A in the indicated cell types from female and male subjects; each symbol represents an individual subject; * adj. p < 0.05. (G) Mean expression levels (TPM) of FAM13A in naive CD4 + T cells and classical monocytes from female and male subjects categorized based on genotype at the indicated peak cis-eQTL; each symbol represents an individual subject; * adj. association p < 0.05. (H) RNA-seq analysis of genes (one per row, row-wise Z scores of normalized TPM counts shown) expressed differentially by ex vivo activated hCMV-specific CD4 + T cells following FAM13A siRNA knockdown versus those treated with siControl (adj. p < 0.1 (DESeq2 analysis; Benjamini-Hochberg test)). Each column represents an individual biological replicate sample (siControl, n = 12; siFAM13A, n = 11); the color-code on top refers to the specific donors (n = 4). (I) Representative FACS plots showing intracellular staining of IL-2 and IL-22 in memory CD4 + T cells activated for 6 hr with PMA and Ionomycin (after knockdown with siRNA pool for control siRNA or FAM13A); frequencies of cytokine producing cells for IL-22, IFN-g and IL-2 in each donor are shown below (n = 10); *p < 0.05 by Wilcoxon matched-pairs signed-rank test; NS, not significant. (J) Mean expression levels (TPM) of sex-biased transcripts in the indicated cell types from female and male subjects; each symbol represents an individual subject; * adj. p < 0.05. investigate the function of FAM13A in T cells, we performed a screening assay that is based on transcriptomic analysis of antigen-specific T cells following FAM13A knockdown ( Figure 6H and S6D-S6F). We found that IL22 transcript level was most significantly reduced in FAM13A knock down conditions compared to control siRNA treatment ( Figure 6H ). We then independently confirmed at the protein level a significant reduction in the proportion of IL-22 producing memory CD4 + T cells following FAM13A knockdown ( Figure 6I and S6G-S6I ). Our results suggested that FAM13A is a positive regulator of IL-22 production by memory CD4 + T cells, and thus, females with higher expression of FAM13A are likely to have more pronounced IL-22 responses in vivo. IL-22 acts on epithelial cells to promote the release of anti-microbial peptides and chemokines as well as wound healing and regenerative gene programs, and thus plays an important role in barrier immunity as well as in promoting excessive inflammatory responses in skin diseases, where IL-22 blocking therapies have shown success (Guttman-Yassky et al., 2018) . Recent studies have found that serum and sputum IL22 levels were elevated in patients with COPD (Zhang et al., 2013) , implying that IL-22 may also have a pathogenic role in COPD. Further studies in model organisms are required to confirm the link between FAM13A-induced IL-22 production by T cells and COPD pathogenesis.
We also found female-biased expression of NLRP2, which encodes an intracellular pattern recognition receptor from the NOD-like receptor (NLR) family NLRP2, which is involved in inflammasome assembly and secretion of caspase-1-dependendent inflammatory cytokines such as IL-1b (Van Gorp et al., 2014) ( Figure 6J and Figure S6J ). PTGER2, which encodes the prostaglandin receptor E2 (EP2), displayed one of the most significant female-biased increased expression patterns, specifically in naive and memory T cell subsets ( Figure 6J and Figure S6J ). Prostaglandin E2 signaling through EP2 has been shown to promote the differentiation and pro-inflammatory functions of human and murine T H 17 and T H 1 cells (Boniface et al., 2009 ). Furthermore, blocking EP2 receptors in T cells has been shown to be effective in preventing the development of arthritis in mouse models (Sreeramkumar et al., 2016) . Given the increased propensity of women to develop autoimmune arthritis and the pathogenic role of T H 17 cells in driving its disease pathogenesis, we speculate that the increased expression of PTGER2 transcripts in females may play a role in amplifying pathogenic T H 17 responses that lead to the development of arthritis. Further functional studies are required to formally test these hypotheses.
Overall, we report on transcripts with sex-biased expression in specific immune cell types and hypothesize that their products may play an important role in driving the sex differences in immune cell function.
DISCUSSION
Despite robust associations between genetic variants and several human diseases, the molecular mechanisms of how non-coding genetic variants perturb gene expression remains unclear in most cases. To address this gap, several large-scale studies have described the association of common genetic variants with gene expression in a wide range of tissues (GTEx Con-sortium, 2015; Battle et al., 2017) and uncovered the scale of eGenes (nearly 80% of all protein-coding transcripts) and the tissue types where their effects were observed. However, previously published eQTL studies in immune cell types were restricted to either heterogeneous populations or a small number of homogeneous cell types, thus making it difficult to tease out cell-specificity of eQTLs. Therefore, the simultaneous study of multiple and diverse cell types is essential to uncover all potential cell-specific effects of genetic variants.
In this first report from the DICE project, we describe results of transcriptomic and eQTL analyses of 13 immune cell types ex vivo as well as activated naive CD4 + and CD8 + T cells. We discovered a total of 12,254 genes with cis-eQTLs and a large fraction (41%) of these genes showed a strong cis-association with genotype only in a single cell type. The novelty and strength of our study is the simultaneous analysis of many purified cell types and conditions (n = 15) from the same subjects (n = 91) compared to previous reports where just a few purified immune cell types were compared. This approach allowed us to map cell-specific effects of genetic variants and, importantly, to link GWAS variants to cell types where their effects are most pronounced. We found that biological sex had a profound effect on the gene expression profiles of immune cells, with a total of over 1,800 genes showing sex-biased expression patterns. We report on several sex-biased genes that may contribute to the risk of developing autoimmune diseases in female subjects as well as explain the previously reported differences in response to infections and vaccination.
Overall, the DICE project provides a reference of transcriptomic and eQTL data for the human immune system, which is likely to facilitate mechanistic and functional investigations into the role of disease risk variants in relevant cell types. Additionally, the sex-related differences evident in various immune cell types will spur interest in understanding the biological consequences of such changes. The next phases of the DICE project will further enrich this dataset with descriptions from additional rare immune cell types and the inclusion of cell-specific epigenomic profiles that can allow pinpointing functional diseaserisk variants.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
The Institutional Review Board (IRB) of the La Jolla Institute for Allergy and Immunology (LJI; IRB protocol no. SGE-121-0714) approved the study. A total of 91 healthy volunteers were recruited in the San Diego area, who provided leukapheresis samples at the San Diego Blood Bank (SDBB) after written informed consent. The cohort consisted of 54 males and 37 female subjects with a median age of 27 years (range 18 to 61 years). All study subjects self-reported ethnicity and race details, and were tested negative for hepatitis B, hepatitis C and human immunodeficiency virus (HIV). Details of the study subjects are provided in Table S1A .
METHOD DETAILS
Sample processing
Peripheral blood mononuclear cells (PBMC) were obtained from leukapheresis samples by density gradient centrifugation according to the manufacturer's instructions and cryopreserved in liquid nitrogen. For the isolation of immune cell types of interest, cryopreserved PBMCs were thawed, washed, stained directly with cocktails of fluorescently conjugated antibodies or pre-enriched for total B cells or memory CD4 + T cells using the 'Human B Cell Isolation Kit II' (Miltenyi Biotec; or the 'Memory CD4 + T Cell Isolation Kit' (Miltenyi Biotec; , respectively, following the manufacturer's instructions before staining with antibodies in four different FACS panels ( Figure S1 and Table S6A ) and sorted on a BD FACSAria II (Becton Dickinson) using the gating strategies shown in Figures S1A-S1D; flow cytometry data were analyzed using FlowJo software (version 10). The FACS-sorted cells were washed and lysed in TRIzol solution (Invitrogen) for subsequent isolation of total RNA. For activation conditions, FACS-sorted naive CD4 + and CD8 + T cells were resuspended at a concentration of 1x10 6 /mL in 1 mL of pre-warmed IMDM medium, supplemented with 5% (vol/vol) heat-inactivated fetal bovine serum (FBS) and 2% (vol/vol) human AB serum (CellGro), and activated ex vivo with GIBCO Dynabeads Human T-Activator CD3/CD28 (ThermoFisher Scientific) at a bead-to-cell ratio of 1:1 for 4 hr at 37 C.
RNA sequencing
Total RNA was purified using the miRNeasy Micro Kit (QIAGEN), quantified as described previously , and quality assessed using the High Sensitivity RNA ScreenTape Kit (Agilent Life Sciences). Uniquely indexed Illumina sequencing libraries were generated from 180-600 ng of purified total RNA per sample using the TruSeq Stranded mRNA HT Sample Prep Kit (Illumina). Sequencing library preparation steps were performed in a 96-well format, utilizing the automated platform Biomek FXP (Beckman Coulter), to reduce assay-to-assay variability. Samples failing any quality control step (RNA quality and quantity, PCR amplification, library fragment size) were eliminated from further downstream steps. Libraries were sequenced on the HiSeq 2500 Illumina platform to obtain 50-bp single-end reads (HiSeq SBS Kit v4; Illumina), generating a total of over 33.1 billion uniquely mapped reads (median of 20.1 million uniquely mapped reads per sample) (Table S1B) .
RNA-Seq analysis
RNA-seq data were mapped against the hg19 reference genome using TopHat v1.4.1 (Trapnell et al., 2009 ) and GENCODE annotation v19 (GRCh37.p13) (Harrow et al., 2012) as gene reference model (including a total of 57,820 annotated transcripts, subclassified into 20,776 protein-coding genes, 13,870 long non-coding RNAs (lncRNA), 9,013 short non-coding RNAs (sncRNA) and 14,161 pseudogenes). Sequencing read coverage per gene was counted using HTSeq (https://htseq.readthedocs.io/en/ release_0.10.0/) (Anders et al., 2015) and transcript abundance expressed as transcripts per million (TPM) units (Wagner et al., 2012) . Transcripts with mean TPM < 1.0 across all samples of a given cell type were excluded from the analysis. The identity of all individual RNA-Seq samples was confirmed by cross-comparison with genotyping data for a given subject by genome-wide analysis of SNPs overlapping exons. We observed no batch effects by standard principal component analysis and multidimensional scaling analysis. To diminish the effects of possible outliers, the regularized log transformation of the DESeq2 package (Love et al., 2014) was applied and the homoscedastic data were then quantile-normalized. Further, samples from each specific cell types were processed for RNA-Seq in one batch to avoid any experimental batch effects.
Differentially expressed (DE) genes across cell types (and activation conditions) were identified by pairwise comparisons using DESeq2 (Love et al., 2014) ; we considered a transcript to be expressed differentially by any comparison when the DESeq2 analysis resulted in a Benjamini-Hochberg adj. p value of < 0.05 and fold change (FC) R 2. Sex-biased transcripts were identified by performing pairwise comparison (female (n = 37) versus male (n = 54) subjects) using DESeq2 and considering ancestry and age as covariates; we considered a transcript expressed differentially when the DESeq2 analysis resulted in a Benjamini-Hochberg adj. p value of < 0.05. Shared expression of transcripts across cell types was determined using the jvenn diagram viewer (http:// jvenn.toulouse.inra.fr/app/index.html) (Bardou et al., 2014) .
Clustering, statistical analysis and data display Unbiased hierarchical clustering (HC) was performed to determine gene expression similarities of single samples across cell types using the TPM values in a log2-transformed scale (a value of 1 was added prior to transformation to account for values = 0). Distance metrics were obtained based on Spearman correlation as D = 1 -abs(spearman_corr); the average method was used for hierarchical clustering using the 1,000 most variable transcripts expressed. Spearman correlation coefficient (r value) was calculated to assess significance of correlations between the levels of any two components of interest. Principal component analysis (PCA) was performed on the entire matrix of expressed transcripts and a set of first principal components were used to perform t-SNE dimensional reduction. GraphPad Prism 7.0d software was used for generating graphs and performing statistical significance tests. The R package with custom scripts was utilized for generating dendrograms, t-SNE plots, heatmaps and volcano plots.
Genotyping, imputation and determination of eQTL Genomic DNA was isolated from PBMC using the DNeasy Blood & Tissue Kit (QIAGEN) and utilized for genotyping using the Infinium Multi-Ethnic Global-8 Kit (Illumina) following the manufacturer's instructions. Raw data from the genotyping analysis was exported using GenomeStudio v2011.1 (Illumina). The data quality was assessed using the snpQC package (Gondro et al., 2014) for R v3.2.3 (http://www.R-project.org) and low-quality SNPs were removed for downstream analysis: SNPs failing in more than 5% of the samples and SNPs with Illumina's GC scores less than 0.2 in more than 10% of the samples were filtered out. Sex, ethnicity and relatedness of the subjects was inferred from the genotype data using PLINK v1.90b3w (Purcell et al., 2007) . IMPUTE v2.3.2 (Howie et al., 2009 ) was used to phase observed genotypes and impute SNPs using the 1000 Genomes Project phase 3 (Auton et al., 2015) as the reference panel, resulting in > 82 million imputed SNPs ($84.5 million SNPs in total; about 5.8 million SNPs were utilized in eQTL analysis). Notably, the eQTL analysis did not cover the pseudoautosomal regions of chr X or chr Y, thereby slightly lowering the annotated transcript count from 57,820 to 57,215 (605 missing genes).
To identify eQTLs, the full set of SNPs (measured and imputed) was tested for association with the expression of sequenced genes using the Matrix eQTL package v2.1.1 (Shabalin, 2012) . Briefly, a linear model was fitted for the expression of each transcript for the underlying genotype of all SNPs located within a window around the annotated transcription start site (TSS) of a given gene (±1 Mb of TSS). The first two principal components of the genotyping data were used as covariates to minimize possible differences introduced by the different ancestry in the samples. SNPs missing for more than 5% of the samples or with a minimum allele frequency (MAF) lower than 5% were removed from the analysis. The gene expression data were processed utilizing an approximation (Ballouz et al., 2015) of the criteria established in the Sequencing Quality Control (SEQC) project by the SEQC/MAQC-III Consortium (SEQC/MAQC- III Consortium, 2014) . Briefly, transcripts with low expression values -the bottom one-third of all transcripts for at least 80% of the samples -were filtered out. The regularized log transformation of the DESeq2 package (Love et al., 2014) was applied and the homoscedastic data were then quantile-normalized to diminish the effects of possible outliers. For each transcript, the associated SNP with the lowest p value was selected and utilized to correct for multiple comparisons. The permutation-based p values were calculated by random shuffling of the sample labels and test statistics were then recalculated as described above. A null distribution was built and corrected p values, Q values and false discovery rate (FDR; adj. association p value) were calculated using the qvalue package (https://github.com/jdstorey/qvalue) (Storey et al., 2015) . For the determination of cis-acting eQTL and affected transcripts and their comparison across cell types, the following thresholds were applied: FDR < 0.05, raw p value < 0.0001 and TPM > 1.0. If not stated otherwise, the associated SNP (called as peak SNP) with the lowest FDR and p value closest to the TSS was chosen for a given transcript.
GWAS SNP database construction and analysis
To define the collection of SNPs from GWAS studies, we downloaded the dataset of the Phenotype-Genotype Integrator (PheGenI) (Ramos et al., 2014) , which merges NHGRI GWAS Catalog data with several databases of the National Center for Biotechnology Information (NCBI), including Gene, dbGaP, OMIM, eQTL and dbSNP (September 2017; https://www.ncbi.nlm.nih.gov/gap/ phegeni). SNP positions were back-translated from PheGenI's GRCh38 annotation to GRCh37.p13 using SNPTracker (Deng et al., 2015) , and the resulting catalog of SNP-trait associations included 14,321 significant associations (lead GWAS SNPs; defined as p < 5 3 10 À8 ) and 846 distinct phenotypes/traits. Linkage disequilibrium (LD) was calculated using PLINK v1.90b3w (Purcell et al., 2007) for continental 'super populations' (AFR, AMR, EAS, EUR, SAS) based on data from the phase 3 of the 1000 Genomes Project (Auton et al., 2015) . SNPs in tight genetic linkage with GWAS lead SNPs (LD threshold r 2 > 0.8) in any of the five super-populations were retrieved along with the SNP information (e.g., genomic location, allelic variant, allele frequencies). Utilizing this dataset, GWAS SNPs (lead SNPs and SNPs in LD) were analyzed for overlap with cis-eQTLs (FDR < 0.05, raw p value < 0.0001 and TPM > 1.0) separately for each cell type to identify transcripts regulated by SNPs in haploblocks containing GWAS lead SNP(s).
Knowledge-based network generation and pathway analysis
The biological relevance of differentially expressed transcripts identified by DESeq2 analysis was investigated using the Ingenuity Pathways Analysis (IPA) platform. The enrichment of canonical pathways (pre-defined, well-described metabolic and signaling pathways curated from literature reviews) among these transcripts was assessed, with significance determined by right-tailed Fisher's exact test (p < 0.05). For network analysis, differentially expressed transcripts were progressively linked together on the basis of a measure of their interconnection, derived from previously characterized functional interactions.
Validation of gene function in primary immune cells 4-1BB surface expression studies: Naive CD4 + T cells were isolated from PBMC using the 'Naive CD4 + T Cell Isolation Kit II' (Miltenyi Biotec; . Subsequently, the naive CD4 + T cells were stimulated with pre-coated anti-CD3 antibodies (10 mg/mL) and soluble anti-CD28 antibodies (1 mg/mL) in presence of IL-7 (5 ng/mL; Miltenyi Biotec). The expression of surface markers (4-1BB, CD25, CD69 and HLA-DR) was analyzed by FACS at various time points); see Table S6B for details.
All siRNA knockdown studies were performed as previously described (Schmiedel et al., 2016) . Primary immune cells were negatively pre-enriched for the cell populations of interest by MACS-based isolation (Miltenyi Biotec) following the manufacturer's instructions, and cultured in Iscove's Modified Dulbecco's Medium (IMDM; Invitrogen) supplemented with 5% (vol/vol) heat-inactivated fetal bovine serum (FBS) and 2% (vol/vol) human AB serum (CellGro).
GAB2 and LACC1 knockdown studies: Naive CD4 + T cells were transfected with 0.5 nmoL (per 1 3 10 6 cells) of siRNA pools specific for GAB2 and LACC1 or non-targeting siRNA (ON-TARGETplus SMARTpools from Dharmacon) using the Neon Transfection System (Invitrogen) according to the manufacturer's protocol (settings: 2,200 V, 10 ms, 3 pulses). Knockdown efficiency was analyzed 48 hr after transfection by real-time PCR for transcript levels and the viability of cells was analyzed by FACS-based Annexin-V and DAPI staining (data not shown). Subsequently, the siRNA-transfected naive CD4 + T cells were stimulated with pre-coated anti-CD3 antibodies (3 mg/mL), soluble anti-CD28 antibodies (1 mg/mL) and IL-7 (5 ng/mL; Miltenyi Biotec), in presence or absence of the TLR1/2 ligand Pam3CSK4 (100 ng/mL; Invivogen). Transcript levels of cytokines were analyzed by real-time PCR after 6 hr of stimulation, the surface expression of activation markers was measured by FACS after 48 hr of stimulation. Total RNA was extracted using the miRNeasy Micro Kit (QIAGEN); cDNA was reverse-transcribed with the SuperScript III First-Strand Synthesis System (Life Technologies). Real-time PCR was employed the Fast Start Universal SYBR Green Master Mix (Roche); see Table S6C for primer sequences. Data were acquired on the QuantStudio 6 Flex (Applied Biosystems); all results are presented in arbitrary units relative to expression of the housekeeping gene YWHAZ.
NAB1 and SYNGR1 knockdown studies: NK cells were isolated from PBMC using the 'NK Cell Isolation Kit' (Miltenyi Biotec; and transfected with 0.5 nmoL (per 1 3 10 6 cells) of siRNA pools specific for NAB1 and SYNGR1 or nontargeting siRNA (ON-TARGETplus SMARTpools from Dharmacon) using the Neon Transfection System (Invitrogen) according to the manufacturer's protocol (settings: 1,900 V, 10 ms, 3 pulses). Knockdown efficiency was analyzed as described above. Subsequently, the siRNA-transfected NK cells were stimulated with pre-coated human IgG (3 mg/mL) or K-562 target cells (cell:cell ratio 1:1). The cytokine secretion was measured after 24 hr of stimulation with U-PLEX assay kits (Meso Scale Discovery) following the manufacturer's instructions. The degranulation of lytic granules by NK cells after culture with K-562 target cells for 3 hr was assessed by surface staining for CD107a.
FAM13A knockdown studies: Memory CD4 + T cells were isolated from PBMC using the 'Memory CD4 + T Cell Isolation Kit' (Miltenyi Biotec; and transfected with 0.5 nmoL (per 1 3 10 6 cells) of siRNA pools specific for FAM13A or non-targeting siRNA (ON-TARGETplus SMARTpools from Dharmacon) using the Neon Transfection System (Invitrogen) according to the manufacturer's protocol (settings: 2,200 V, 10 ms, 3 pulses). Knockdown efficiency was analyzed as above. Subsequently, the siRNAtransfected memory CD4 + T were intracellularly stained (ICS) for cytokine detection after stimulation with PMA and Ionomycin for 6 hr; Brefeldin A (5 mg/mL; Sigma-Aldrich) was added for the final 2 hr of culture. ICS assay was performed following the instructions of BioLegend's 'Intracellular flow cytometry staining protocol'.
Screening for effects of FAM13A knockdown in antigen-specific T cells: The activation and FACS-based enrichment of antigenspecific CD4 + T cells from PBMC was previously described (Bacher et al., 2016) , modifications to the protocol are outlined in Figure S6D . In brief, CD4 + T cells were isolated from PBMC using the 'CD4 + T Cell Isolation Kit' (Miltenyi Biotec; and transiently transfected with 0.5 nmoL (per 1 3 10 6 cells) of siRNA pool specific for FAM13A or non-targeting siRNA (ON-TARGETplus SMARTpools from Dharmacon) using the Neon Transfection System (Invitrogen) according to the manufacturer's protocol (settings: 2,200 V, 10 ms, 3 pulses). Knockdown efficiency was analyzed as described above. 48 hr after transfection, siRNA-transfected CD4 + T cells were pooled with autologous PBMC (stained with CellTrace Violet (ThermoFisher Scientific) to discriminate from siRNA-transfected CD4 + T cells) and rested for 2 hr. Subsequently, PepTivator hCMV pp65 (Miltenyi Biotec) was added and the cells were cultured for 6 hr in presence of a blocking anti-CD40 antibody (Miltenti Biotec). For FACS-based enrichment of activated hCMV-specific CD4 + T cells, cells were stained for the activation markers CD154 and 4-1BB. For each replicate, 400 CD154 + (marker of antigen-specific activation) non-naive CD4 + T cells were FACS-sorted directly into lysis buffer using a BD FACSAria Fusion (Becton Dickinson); the gating strategy is shown in Figure S6F . RNA isolation and preparation of RNA-Seq libraries was done following the low-input protocol described previously (Rosales et al., 2018) . Differentially expressed (DE) genes across samples from treatment with siRNA pool for FAM13A or non-targeting siRNA were identified by pairwise comparisons of all samples including replicates, using DESeq2 (Love et al., 2014) ; we considered a transcript to be expressed differentially in a comparison when the DESeq2 analysis resulted in a Benjamini-Hochberg adj. p value of < 0.1.
QUANTIFICATION AND STATISTICAL ANALYSIS
Processing of data, applied methods and codes are described in the respective section in the STAR Methods. The number of subjects, samples and replicates analyzed, and the statistical test performed are indicated in the figure legends.
Any samples failing established quality controls (QC) were eliminated from downstream analysis; assay details and QCs on RNA-Seq samples included are provided in Table S1B (1,544 samples in total). Differentially expressed (DE) genes across cell types (and activation conditions) were identified by pairwise comparisons using DESeq2; we considered a transcript to be expressed differentially by any comparison when the DESeq2 analysis resulted in a Benjamini-Hochberg adj. p value of < 0.05 and fold change (FC) R 2. Sex-biased transcripts were identified by performing pairwise comparison (female (n = 37) versus male (n = 54) subjects) using DESeq2 and considering ancestry and age as covariates; we considered a transcript expressed differentially when the DESeq2 analysis resulted in a Benjamini-Hochberg adj. p value of < 0.05.
To identify eQTLs, the full set of SNPs (measured and imputed) was tested for association with the expression of sequenced genes using the Matrix eQTL package v2.1.1. For the determination of cis-acting eQTL and affected transcripts and their comparison across cell types, the following thresholds were applied: FDR < 0.05, raw p value < 0.0001 and TPM > 1.0. If not stated otherwise, the associated SNP (called as peak SNP) with the lowest FDR and p value closest to the TSS was chosen for a given transcript.
Statistical analysis for comparison between two groups was assessed with Student's paired two-tailed t test or Wilcoxon matchedpairs signed-rank test using GraphPad Prism 7.0d. The two-way ANOVA test was utilized for the time course experiment.
DATA AND SOFTWARE AVAILABILITY
The DICE project provides anonymized data for public access at https://dice-database.org. Individual-specific sequencing and genotype data were submitted to the database of Genotypes and Phenotypes (dbGaP). The accession number for data reported in this paper is: phs001703.v1.p1. Figure S1 . Sorting Strategies, Immune Cell Types Isolated, and Additional Data for RNA-Seq Analysis, Related to Figures 1 and 2 (A-D) Representative FACS plots describing the sorting strategies used for the isolation of the indicated immune cell types using four different FACS panels from peripheral blood mononuclear cells (PBMC). (E) Surface markers used for isolation of the indicated cell types (details in Table S6A ). (F) Relative proportions of the indicated immune cell populations in PBMC samples (n = 91 each); each symbol represents an individual subject. (G) RNA-seq analysis of 1,544 samples (details in Table S1B ) showing the total number of detected protein-coding transcripts and lncRNAs categorized based on their mean expression levels (TPM, transcript per million) in the indicated cell types and activation conditions. T cells  TFH cells  TREG cells   Memory  TREG cells  TH1 cells  TH1/17 cells  TH17 cells  TH2 cells CD59 (rs7104220) * * Memory TREG cells   TH1 cells  TH1/17 cells  TH17 cells  TH2 cells  TFH cells 
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